Evidence map›Paper›PMID 11756539›Full record

ArticleMolecular and cellular biology2002

hpr1Delta affects ribosomal DNA recombination and cell life span in Saccharomyces cerevisiae.

Robert J Merker, Hannah L Klein

Abstract read
In one paragraph

Article in Molecular and cellular biology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Robert J MerkerDepartment of Biochemistry and Kaplan Comprehensive Cancer Center, New York University School of Medicine, New York, New York 10016, USA.
Hannah L Klein
New York University · US

Funding

GENETIC BEHAVIOR OF REPEATED SEQUENCESR01GM030439 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI KLEIN, HANNAH L · 1985 to 2001
$739k
NIGMS NIH HHS GM30439
6 · The paper itself

Abstract

Multiple genetic pathways have been shown to regulate life span and aging in the yeast Saccharomyces cerevisiae. Here we show that loss of a component of the RNA polymerase II complex, Hpr1p, results in a decreased life span. Although hpr1Delta mutants have an increased rate of recombination within the ribosomal DNA (rDNA) array, this is not accompanied by an increase in extrachromosomal rDNA circles (ERCs). Analyses of mutants that affect replication of the rDNA array and suppressors that reverse the phenotypes of the hpr1Delta mutant show that the reduced life span is associated with increased genomic instability but not with increased ERC formation. The hpr1Delta mutant acts in a pathway distinct from previously described mutants that reduce life span.

Indexed as

DNA-Binding ProteinsSaccharomyces cerevisiae ProteinsSilent Information Regulator Proteins, Saccharomyces cerevisiaeDNA, FungalDNA HelicasesDNA, RibosomalFungal ProteinsGenes, FungalHistone DeacetylasesMutationNuclear ProteinsPhenotypeRecombination, GeneticRecQ HelicasesSaccharomyces cerevisiaeSirtuin 2DNA-Binding ProteinsDNA, FungalDNA HelicasesDNA, RibosomalFOB1 protein, S cerevisiaeFungal ProteinsHistone DeacetylasesHPR1 protein, S cerevisiaeNuclear ProteinsRecQ HelicasesSaccharomyces cerevisiae ProteinsSGS1 protein, S cerevisiaeSilent Information Regulator Proteins, Saccharomyces cerevisiaeSIR2 protein, S cerevisiaeSirtuin 2SirtuinsTrans-Activators

Identifiers

PMID11756539
PMCPMC139738
OpenAlexW2164578928

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.